The rotation into cyclical stocks isn’t over, but investors should use volatility to ‘build positions’ in tech, UBS says Carla Mozee 11 mrt 2021
Aveo extends gains to 106% after drug maker wins FDA approval for kidney cancer treatment Carla Mozee 11 mrt 2021
Exela Technologies leaps 179% after winning $90 million data-management contract from ‘major’ health insurer Carla Mozee 09 mrt 2021
The Fed needs to convince stock investors that their rate hike expectations are priced in ’too aggressively’, Barclays says Carla Mozee 09 mrt 2021
The recent sell-off has taken the ‘frothiness’ out of SPACs and has made mega-cap tech stocks look more attractive, Bespoke Investment says Carla Mozee 08 mrt 2021
Second Sight Medical Products soars 592% after the FDA approves its visual prosthetic system Carla Mozee 05 mrt 2021
